Identification of the regulatory mechanism of ACE2 in COVID-19–induced kidney damage with systems genetics approach

被引：0
作者：
Xueling Yang
Chunhua Lin
Jian Liu
Ya Zhang
Tingzhi Deng
Mengna Wei
Shuijing Pan
Lu Lu
Xuri Li
Geng Tian
Jia Mi
Fuyi Xu
Chunhua Yang
机构：
[1] Binzhou Medical University,Shandong Technology Innovation Center of Molecular Targeting and Intelligent Diagnosis and Treatment
[2] The Affiliated Yantai Yuhuangding Hospital of Qingdao University,Department of Urology
[3] The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital,Department of Plastic Surgery
[4] University of Tennessee Health Science Center,Department of Genetics, Genomics and Informatics
[5] Zhongshan Ophthalmic Center,State Key Laboratory of Ophthalmology
[6] Sun Yat-Sen University,undefined
来源：
Journal of Molecular Medicine | 2023年 / 101卷
关键词：
BXD mice; Kidney; Transcriptome; COVID-19; SARS-CoV-2; RAS; PDGF family;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：449 / 460
页数：11
相关论文
共 50 条
[41]   Blood ACE2 Protein Level Correlates with COVID-19 Severity [J].
Shevchuk, Oksana ;
Pak, Anastasia ;
Palii, Svitlana ;
Ivankiv, Yana ;
Kozak, Kateryna ;
Korda, Mykhaylo ;
Vari, Sandor G. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (18)
[42]   The Impact of ACE2 Gene Polymorphism in the Development of COVID-19 Disease [J].
Karahalil, Bensu ;
Elkama, Aylin .
GAZI MEDICAL JOURNAL, 2020, 31 (3A) :518-521
[43]   The effects of ACE2 expression mediating pharmacotherapy in COVID-19 patients [J].
van Kimmenade, R. R. J. ;
Belfroid, E. ;
Hoogervorst-Schilp, J. ;
Siebelink, H. J. ;
Janssen, C. W. ;
Pinto, Y. .
NETHERLANDS HEART JOURNAL, 2021, 29 (SUPPL 1) :20-34
[44]   Potential influence of COVID-19/ACE2 on the female reproductive system [J].
Yan Jing ;
Li Run-Qian ;
Wang Hao-Ran ;
Chen Hao-Ran ;
Liu Ya-Bin ;
Gao Yang ;
Chen Fei .
MOLECULAR HUMAN REPRODUCTION, 2020, 26 (06) :367-373
[45]   Lions, tigers and kittens too: ACE2 and susceptibility to COVID-19 [J].
Mathavarajah, Sabateeshan ;
Dellaire, Graham .
EVOLUTION MEDICINE AND PUBLIC HEALTH, 2020, (01) :109-113
[46]   The effects of ACE2 expression mediating pharmacotherapy in COVID-19 patients [J].
R. R. J. van Kimmenade ;
E. Belfroid ;
J. Hoogervorst-Schilp ;
H. J. Siebelink ;
C. W. Janssen ;
Y. Pinto .
Netherlands Heart Journal, 2021, 29 :20-34
[47]   Investigating the ACE2 polymorphisms in COVID-19 susceptibility: An in silico analysis [J].
Pouladi, Nasser ;
Abdolahi, Sepehr .
MOLECULAR GENETICS & GENOMIC MEDICINE, 2021, 9 (06)
[48]   ACE2 and COVID-19: using antihypertensive medications and pharmacogenetic considerations [J].
Snyder, Eric M. ;
Johnson, Bruce D. .
PHARMACOGENOMICS, 2020, 21 (10) :695-703
[49]   Design of an engineered ACE2 as a novel therapeutics against COVID-19 [J].
Payandeh, Zahra ;
Rahbar, Mohammad Reza ;
Jahangiri, Abolfazl ;
Hashemi, Zahra Sadat ;
Zakeri, Alireza ;
Jafarisani, Moslem ;
Rasaee, Mohammad Javad ;
Khalili, Saeed .
JOURNAL OF THEORETICAL BIOLOGY, 2020, 505
[50]   ACE2 Serum Levels as Predictor of Infectability and Outcome in COVID-19 [J].
Maza, Maria del Carmen ;
Ubeda, Maria ;
Delgado, Pilar ;
Horndler, Lydia ;
Llamas, Miguel A. ;
van Santen, Hisse M. ;
Alarcon, Balbino ;
Abia, David ;
Garcia-Bermejo, Laura ;
Serrano-Villar, Sergio ;
Bastolla, Ugo ;
Fresno, Manuel .
FRONTIERS IN IMMUNOLOGY, 2022, 13
12345